| Item Type | Name |
|
Concept
|
Caspase 8
|
|
Concept
|
Oxidative Stress
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Cell Movement
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
Smad1 Protein
|
|
Concept
|
Antigen Presentation
|
|
Concept
|
Multidrug Resistance-Associated Proteins
|
|
Concept
|
Membrane Glycoproteins
|
|
Concept
|
Hepatocyte Growth Factor
|
|
Concept
|
Sepsis
|
|
Concept
|
Radiation Dosage
|
|
Concept
|
Adrenal Cortex Neoplasms
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Sarcoma, Synovial
|
|
Concept
|
Cytokines
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Follistatin
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Prognosis
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Oncogene Proteins, Fusion
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Retinal Neovascularization
|
|
Concept
|
Androstadienes
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
CD8 Antigens
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Sarcoma, Kaposi
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Bone Morphogenetic Protein 7
|
|
Concept
|
Quinazolines
|
|
Concept
|
Cell Division
|
|
Concept
|
APACHE
|
|
Concept
|
Receptors, OX40
|
|
Concept
|
Cyclins
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Diabetic Retinopathy
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Macrophages
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Co-Repressor Proteins
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
ATP-Binding Cassette Transporters
|
|
Concept
|
ras Proteins
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Glucocorticoid-Induced TNFR-Related Protein
|
|
Concept
|
Oligonucleotides, Antisense
|
|
Concept
|
Interleukin-8
|
|
Concept
|
Clinical Trials, Phase I as Topic
|
|
Concept
|
Proto-Oncogenes
|
|
Concept
|
Hypoxia
|
|
Concept
|
RNA Interference
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
RNA Editing
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Oxidative Phosphorylation
|
|
Concept
|
Cisplatin
|
|
Concept
|
Nuclear Proteins
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
STAT6 Transcription Factor
|
|
Concept
|
Transcription Factors
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Toll-Like Receptor 8
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Dose-Response Relationship, Radiation
|
|
Concept
|
3' Untranslated Regions
|
|
Concept
|
Interleukin-6
|
|
Concept
|
Receptors, Immunologic
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Stromal Cells
|
|
Concept
|
Cell Growth Processes
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
RNA, Untranslated
|
|
Concept
|
Tumor Stem Cell Assay
|
|
Concept
|
Enhancer Elements, Genetic
|
|
Concept
|
Radiation Tolerance
|
|
Concept
|
AMP-Activated Protein Kinases
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Caspase 3
|
|
Concept
|
Macular Edema
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Chemokines, CC
|
|
Concept
|
Hypoxia-Inducible Factor 1
|
|
Concept
|
Radioimmunotherapy
|
|
Concept
|
Proto-Oncogene Proteins c-met
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Transfection
|
|
Concept
|
Databases as Topic
|
|
Concept
|
Herpesvirus 8, Human
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Risk Assessment
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Risk Factors
|
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
|
Concept
|
Cesium Radioisotopes
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Interferon Type I
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Pyrrolidinones
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Tumor Suppressor Proteins
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Galectin 1
|
|
Concept
|
Repressor Proteins
|
|
Concept
|
Tryptophan
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Bone Morphogenetic Proteins
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Protons
|
|
Concept
|
Cell Hypoxia
|
|
Concept
|
RNA, Neoplasm
|
|
Concept
|
Mitogen-Activated Protein Kinase 14
|
|
Concept
|
Antigens, CD
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Activins
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
fas Receptor
|
|
Concept
|
Phosphorylation
|
|
Academic Article
|
C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.
|
|
Academic Article
|
Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy.
|
|
Academic Article
|
MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases.
|
|
Academic Article
|
MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer.
|
|
Academic Article
|
MicroRNAs in body fluids--the mix of hormones and biomarkers.
|
|
Academic Article
|
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.
|
|
Academic Article
|
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts.
|
|
Academic Article
|
Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.
|
|
Academic Article
|
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
|
|
Academic Article
|
Galectin-1 and immune suppression during radiotherapy.
|
|
Academic Article
|
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma.
|
|
Academic Article
|
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.
|
|
Academic Article
|
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
|
|
Academic Article
|
Strategies for combining immunotherapy with radiation for anticancer therapy.
|
|
Academic Article
|
PDL1 Regulation by p53 via miR-34.
|
|
Academic Article
|
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma
|
|
Academic Article
|
mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.
|
|
Academic Article
|
Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
|
|
Academic Article
|
In vitro effect of glucocorticoids on nasal polyps.
|
|
Academic Article
|
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.
|
|
Academic Article
|
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.
|
|
Academic Article
|
Optimizing Radiotherapy with Immunotherapeutic Approaches.
|
|
Academic Article
|
The HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.
|
|
Academic Article
|
Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.
|
|
Academic Article
|
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.
|
|
Academic Article
|
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia.
|
|
Academic Article
|
Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.
|
|
Academic Article
|
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects.
|
|
Academic Article
|
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.
|
|
Academic Article
|
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
|
|
Concept
|
RAW 264.7 Cells
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Fluticasone
|
|
Concept
|
Erlotinib Hydrochloride
|
|
Concept
|
Ranibizumab
|
|
Concept
|
Zinc Finger E-box-Binding Homeobox 1
|
|
Concept
|
Myeloid-Derived Suppressor Cells
|
|
Concept
|
Ipilimumab
|
|
Concept
|
c-Mer Tyrosine Kinase
|
|
Concept
|
Transcriptome
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
V-Set Domain-Containing T-Cell Activation Inhibitor 1
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
RNA, Long Noncoding
|
|
Concept
|
Polycomb Repressive Complex 1
|
|
Concept
|
Carcinogenesis
|
|
Academic Article
|
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
|
|
Academic Article
|
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials.
|
|
Academic Article
|
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity.
|
|
Academic Article
|
Bone morphogenetic protein 7 promotes resistance to immunotherapy.
|
|
Academic Article
|
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects.
|
|
Academic Article
|
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
|
|
Academic Article
|
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic Cancer.
|
|
Academic Article
|
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance.
|
|
Academic Article
|
Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
|
|
Academic Article
|
Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy.
|
|
Academic Article
|
Pulsed radiotherapy to mitigate high tumor burden and generate immune memory.
|
|
Academic Article
|
NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model.
|
|
Academic Article
|
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy.
|
|
Academic Article
|
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
|
|
Academic Article
|
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
|
|
Academic Article
|
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.
|